KerusCloud®

Don’t roll the dice on your clinical trial.

KerusCloud® allowed us to develop our study design to recognize the transformative potential of EXN407 whilst ensuring we account for and minimize any potential risks.
Loic Lhuillier
Chief Operating Officer

Clinical Trial Simulation Software to De-risk Study Design

KerusCloud® is an advanced clinical trial simulation software that helps research teams de-risk studies by design. This cloud-based platform enables you to model and analyze thousands of virtual trial scenarios—optimizing endpoints, recruitment strategies, and estimand frameworks before a real study begins. With KerusCloud®, you get data-backed insights that accelerate development, reduce costs, and increase the probability of trial success.

Optimize patient recruitment
  • Visualize patient recruitment scenarios: Simulate recruitment rates and site numbers to understand how population choice impacts your study’s length and probability of success.
  • Forecast study timelines more accurately: Analyze your recruitment strategies in silico to better understand the operational landscape and impact of potential adjustments to recruitment strategies, sample sizes, and decision criteria, ensuring your real trial stays on track.

Explore patient recruitment capabilities

Optimize study designs with advanced simulations 
  • Stay ahead of regulatory requirements: Ensure study designs comply with ICH E9(R1) guidelines. Incorporate estimand strategies that align with FDA and EMA requirements, keeping your study compliant while delivering results ready for regulatory approval.
  • Identify the most effective study design: Explore a range of fixed and adaptive study designs in silico to evaluate how they impact study outcomes and enable you to reduce costs, accelerate timelines, and minimize patient burden.
  • Enhance trial flexibility and manage uncertainty: Use KerusCloud’s probabilistic framework to estimate the likelihood of different outcomes as new data emerges, and refine your development plan accordingly.

Explore design & analysis options

Mimic real-world conditions with synthetic data
  • Leverage virtual population data: Manage complex virtual datasets and simulate your study in a way that accurately mimics actual clinical trial dynamics.
  • Access predefined data libraries: Rapidly set up simulations that include virtual patient populations, recruitment scenarios and various adaptive design options.
  • Streamline trial execution: Save time and resources by creating external control arms, reducing the need for extensive recruitment in clinical trials.
  • Maintain patient privacy: Enable the sharing of regulated or sensitive data while maintaining privacy and compliance through anonymization.
  • Address imbalanced or missing data: Generate large, auto-labelled datasets to support predictive modelling, machine learning, and AI so you can address imbalanced data in clinical studies.

Explore dataset generation

Visualize, export, and explore results
  • Choose the right study design the first time: Use the interactive heatmap to visualize how different decisions affect the study’s probability of success.
  • Support transparent decision-making: Share synthetic data, recruitment profiles, simulation results, and reports with your team throughout your trial.
  • Analyze patient populations, recruitment, and trial dynamics: Integrate with R and other analytics tools to create tailored visualizations.

 

Suggested For You

news

June 19th, 2025

MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion 

perspectives

June 17th, 2025

Solving Data Complexity with Real-Time Insights, Predictive AI, and Smarter Decision-Making with Datacise

regulatory intelligence

June 16th, 2025

Key MedDRA Coding Gaps Highlighted at the ISCTM 2025 Scientific Meeting

perspectives

June 10th, 2025

Applying Artificial Intelligence (AI) and Real-World Evidence to Boost Efficiency in Patient Safety Narratives 

perspectives

June 3rd, 2025

Choosing the Right Strategy: Parallel, Sequential, and Staggered Regulatory Submissions 

news

May 28th, 2025

MMS Named Finalist for Fierce CRO Award in Excellence in Client Service and Partnership, CEO shortlisted for the CRO Champion Award 

perspectives

May 28th, 2025

A Season of Change: Why the REMS Industry Consortium Matters More Than Ever

perspectives

May 20th, 2025

Navigating FDA OMOR Meetings: A Comprehensive Guide to Type X, Y, and Z Meetings for OTC Drug Sponsors

perspectives

May 6th, 2025

Why Clinical Trial Simulation Is Reshaping Drug Development: A Q&A with Dr. Aiden Flynn

perspectives

April 24th, 2025

How to Derisk Clinical Development with Unified Trial Design and Regulatory Strategy

perspectives

April 8th, 2025

Updated UK Clinical Trial Regulation: The Key Changes and Impact on Development Safety Update Report (DSUR) Requirements

news

April 3rd, 2025

Datacise by MMS Wins 2025 Data Breakthrough Award for Best Data Science Solution